Trademark Overview
On Tuesday, April 24, 2001, a trademark application was filed for ONSIGHT with the United States Patent and Trademark Office. The USPTO has given the ONSIGHT trademark a serial number of 78060136. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, June 29, 2003. This trademark is owned by Amgenix International, Inc.. The ONSIGHT trademark is filed in the Pharmaceutical Products category with the following description:
Medical diagnostic test kit for the diagnosis of fertility, namely, HCG, LH, FSH and other similar hormones; infectious diseases, namely, Hepatitis B, Hepatitis C, HIV-1/2, Strep A, Strep B, Chlamydia, Toxoplasma, Rubella, Influenza, Malaria, Infectious Mononucleosis, Syphilis, Helicobactor pylon, Tuberculosis, Dengue, Chagas, Rota Virus, Cholera, Salmonella Typhi, Gonorrhea, Tnichomonas, and other bacterial, viral and protozoal infectious diseases; tumor/cancer markers, namely, CEA, AFP, FOB, PSA, and other similar tumor/cancer markers; cardiac markers, namely, for diagnosing Myoglobin, Troponin I, CK-MB, and other similar cardiac markers; allergy, namely IgE and other similar markers, and drugs of abuse, namely, for detecting the presence of THC, Cocaine, Opiates, Amphetamine, Methamphetamine, Barbiturates, Benzodiazepine, PCP, Methadone, Cotinine, and other illegal substances
